These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16122834)

  • 21. Neuropathy target esterase inhibition by organophosphorus esters in human neuroblastoma cells.
    Ehrich M; Correll L; Veronesi B
    Neurotoxicology; 1994; 15(2):309-13. PubMed ID: 7991219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro study of the neuropathic potential of the organophosphorus compounds fenamiphos and profenofos: Comparison with mipafox and paraoxon.
    Emerick GL; Fernandes LS; de Paula ES; Barbosa F; dos Santos NA; dos Santos AC
    Toxicol In Vitro; 2015 Aug; 29(5):1079-87. PubMed ID: 25910916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative studies of O,O-dialkyl-O-chloromethylchloroformimino phosphates: interaction with neuropathy target esterase and acetylcholinesterase.
    Makhaeva GF; Filonenko IV; Yankovskaya VL; Fomicheva SB; Malygin VV
    Neurotoxicology; 1998; 19(4-5):623-8. PubMed ID: 9745921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Degradation of neuropathy target esterase by the macroautophagic lysosomal pathway.
    Long DX; Chang PA; Liang YJ; Yang L; Wu YJ
    Life Sci; 2009 Jan; 84(3-4):89-96. PubMed ID: 19059269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of chromaffin cells from several animal sources for their use as an in vitro model to study the mechanism of organophosphorous toxicity.
    Romero D; Quesada E; Sogorb MA; García-Fernández AJ; Vilanova E; Carrera V
    Toxicol Lett; 2006 Sep; 165(3):221-9. PubMed ID: 16797889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenyl valerate esterases other than neuropathy target esterase and the promotion of organophosphate polyneuropathy.
    Milatovic D; Moretto A; Osman KA; Lotti M
    Chem Res Toxicol; 1997 Sep; 10(9):1045-8. PubMed ID: 9305588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of neuropathy target esterase activity with specific tritiated di-isopropyl phosphorofluoridate-labelled proteins.
    Thomas TC; Ishikawa Y; McNamee MG; Wilson BW
    Biochem J; 1989 Jan; 257(1):109-16. PubMed ID: 2920006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoic acid differentiated SH-SY5Y human neuroblastoma cells: an in vitro model to assess drug neurotoxicity.
    Nicolini G; Miloso M; Zoia C; Di Silvestro A; Cavaletti G; Tredici G
    Anticancer Res; 1998; 18(4A):2477-81. PubMed ID: 9703895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Avian embryonic brain reaggregate culture system. II. NTE activity discriminates between effects of a single neuropathic or nonneuropathic organophosphorus compound exposure.
    Funk KA; Liu CH; Higgins RJ; Wilson BW
    Toxicol Appl Pharmacol; 1994 Jan; 124(1):159-63. PubMed ID: 8291056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurotoxic esterase in rooster testis.
    Lotti M; Wei ET; Spear RC; Becker CE
    Toxicol Appl Pharmacol; 1985 Jan; 77(1):175-80. PubMed ID: 3966239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mipafox-inhibited catalytic domain of human neuropathy target esterase ages by reversible proton loss.
    Kropp TJ; Glynn P; Richardson RJ
    Biochemistry; 2004 Mar; 43(12):3716-22. PubMed ID: 15035642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy.
    Lotti M; Moretto A; Capodicasa E; Bertolazzi M; Peraica M; Scapellato ML
    Toxicol Appl Pharmacol; 1993 Oct; 122(2):165-71. PubMed ID: 8211998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor for advanced glycation end products (RAGE) mediates neuronal differentiation and neurite outgrowth.
    Wang L; Li S; Jungalwala FB
    J Neurosci Res; 2008 May; 86(6):1254-66. PubMed ID: 18058943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. G protein beta2 subunit interacts directly with neuropathy target esterase and regulates its activity.
    Chen R; Chang PA; Long DX; Liu CY; Yang L; Wu YJ
    Int J Biochem Cell Biol; 2007; 39(1):124-32. PubMed ID: 16978909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of neurotoxic esterase in vitro by novel carbamates.
    Randall JC; Ambroso JL; Groutas WC; Brubaker MJ; Richardson RJ
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):173-8. PubMed ID: 9073605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity.
    Winrow CJ; Hemming ML; Allen DM; Quistad GB; Casida JE; Barlow C
    Nat Genet; 2003 Apr; 33(4):477-85. PubMed ID: 12640454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysophospholipase inhibition by organophosphorus toxicants.
    Quistad GB; Casida JE
    Toxicol Appl Pharmacol; 2004 May; 196(3):319-26. PubMed ID: 15094302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro study of the neuropathic potential of the organophosphorus compounds trichlorfon and acephate.
    Fernandes LS; Emerick GL; dos Santos NA; de Paula ES; Barbosa F; dos Santos AC
    Toxicol In Vitro; 2015 Apr; 29(3):522-8. PubMed ID: 25596135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetylcholinesterase and neuropathy target esterase inhibitions in neuroblastoma cells to distinguish organophosphorus compounds causing acute and delayed neurotoxicity.
    Ehrich M; Correll L; Veronesi B
    Fundam Appl Toxicol; 1997 Jul; 38(1):55-63. PubMed ID: 9268605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective inhibitors of fatty acid amide hydrolase relative to neuropathy target esterase and acetylcholinesterase: toxicological implications.
    Quistad GB; Sparks SE; Segall Y; Nomura DK; Casida JE
    Toxicol Appl Pharmacol; 2002 Feb; 179(1):57-63. PubMed ID: 11884237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.